NL
Nuveen LLC Portfolio holdings
AUM
$362B
This Quarter Return
+15.98%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$362B
AUM Growth
+$32.2B
(+9.8%)
Cap. Flow
+$2.54B
Cap. Flow
% of AUM
0.7%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
3,484
New
192
Increased
990
Reduced
1,978
Closed
199
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$7.05B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.25B |
| 3 |
NVIDIA
NVDA
|
+$1.5B |
| 4 |
Amazon
AMZN
|
+$637M |
| 5 |
Cisco
CSCO
|
+$577M |
Top Sells
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$2.48B |
| 2 |
Cintas
CTAS
|
+$1.79B |
| 3 |
UnitedHealth
UNH
|
+$699M |
| 4 |
Apple
AAPL
|
+$586M |
| 5 |
BOLD
Boundless Bio
BOLD
|
+$399M |
Sector Composition
| 1 | Technology | 32.84% |
| 2 | Financials | 12.99% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 9.04% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3051
Corvus Pharmaceuticals
CRVS
$460M
| $272K | ﹤0.01% |
+68,064
| New | +$272K |
|
3052
Global Water Resources
GWRS
$270M
| $271K | ﹤0.01% |
26,628
-6,410
| -19% | -$65.3K |
|
3053
Puma Biotechnology
PBYI
$237M
| $271K | ﹤0.01% |
79,101
| – | – |
|
|
CRGX
3054
DELISTED
CARGO Therapeutics
CRGX
| $271K | ﹤0.01% |
65,680
-10,249
| -13% | -$42.2K |
|
3055
Sky Harbour Group
SKYH
$340M
| $270K | ﹤0.01% |
27,644
+12,422
| +82% | +$121K |
|
3056
Motorcar Parts of America
MPAA
$286M
| $265K | ﹤0.01% |
+23,681
| New | +$265K |
|
3057
Contango ORE
CTGO
$273M
| $265K | ﹤0.01% |
13,611
| – | – |
|
3058
Definitive Healthcare
DH
$431M
| $264K | ﹤0.01% |
67,607
-36,071
| -35% | -$141K |
|
3059
Omeros
OMER
$290M
| $263K | ﹤0.01% |
87,618
-26,439
| -23% | -$79.3K |
|
3060
AMES National
ATLO
$180M
| $263K | ﹤0.01% |
14,751
+163
| +1% | +$2.9K |
|
3061
OP Bancorp
OPBK
$217M
| $262K | ﹤0.01% |
+20,151
| New | +$262K |
|
|
VNET
3062
VNET Group
VNET
$2.24B
| $262K | ﹤0.01% |
37,900
-1,100
| -3% | -$7.59K |
|
3063
Bank7 Corp
BSVN
$460M
| $259K | ﹤0.01% |
+6,194
| New | +$259K |
|
3064
Myomo
MYO
$35.9M
| $259K | ﹤0.01% |
+119,681
| New | +$259K |
|
3065
Clarus
CLAR
$154M
| $258K | ﹤0.01% |
74,360
-14,289
| -16% | -$49.6K |
|
3066
HighPeak Energy
HPK
$896M
| $257K | ﹤0.01% |
26,220
-3,926
| -13% | -$38.5K |
|
|
SEG
3067
Seaport Entertainment Group Inc.
SEG
$306M
| $256K | ﹤0.01% |
13,753
+2,875
| +26% | +$53.6K |
|
3068
Cartesian Therapeutics
RNAC
$262M
| $255K | ﹤0.01% |
24,497
-3,372
| -12% | -$35K |
|
|
MBX
3069
MBX Biosciences, Inc. Common Stock
MBX
$384M
| $253K | ﹤0.01% |
22,143
+7,672
| +53% | +$87.5K |
|
3070
Gores Guggenheim
PSNY
$2.14B
| $253K | ﹤0.01% |
236,100
+169,208
| +253% | +$181K |
|
3071
Priority Technology Holdings
PRTH
$620M
| $252K | ﹤0.01% |
32,441
+7,285
| +29% | +$56.7K |
|
3072
Silvercrest Asset Management
SAMG
$136M
| $249K | ﹤0.01% |
15,690
-4,542
| -22% | -$72K |
|
|
RAPP
3073
Rapport Therapeutics
RAPP
$1.02B
| $249K | ﹤0.01% |
21,873
| – | – |
|
3074
CVRx
CVRX
$210M
| $249K | ﹤0.01% |
42,289
| – | – |
|
|
BBNX
3075
Beta Bionics, Inc. Common Stock
BBNX
$1.09B
| $248K | ﹤0.01% |
17,044
| – | – |
|